Akebia Therapeutics reported $44.33M in Selling and Administration Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 96.68M 9.23M
Agios Pharmaceuticals AGIO:US $ 31.51M 13K
Akebia Therapeutics AKBA:US $ 44.33M 498K
Alnylam Pharmaceuticals ALNY:US $ 154.47M 31.91M
Amgen AMGN:US $ 1.23B 197M
Ardelyx ARDX:US $ 19.34M 5.1M
Astellas Pharma 4503:JP 142.42B 6.51B
AstraZeneca AZN:LN 3.06B 1.03B
Avrobio Inc AVRO:US 10.16M 1.2M
Bayer BAYN:GR 3.94B 346M
Biomarin Pharmaceutical BMRN:US $ 194.62M 22.94M
Exelixis EXEL:US $ 102.86M 3.55M
Fresenius Medical Care FME:GR 871.24M 48.03M
GlaxoSmithKline GSK:LN 2.68B 227M
Intercept Pharmaceuticals ICPT:US $ 50.01M 10.58M
IONIS PHARMACEUT IONS:US $ 34.13M 3.47M
Ironwood Pharmaceuticals IRWD:US $ 28.86M 175K
Karyopharm Therapeutics KPTI:US $ 38.77M 4.21M
Lexicon Pharmaceuticals LXRX:US 8.49M 355K
Moderna Inc MRNA:US 268M 67M
Opko Health OPK:US $ 117.54M 20.68M
Prothena PRTA:US 11.84M 371K
Ptc Therapeutics PTCT:US $ 73.27M 13.28M
Regeneron Pharmaceuticals REGN:US $ 450M 109.6M
Seattle Genetics SGEN:US $ 174.22M 36.71M
Vanda Pharmaceuticals VNDA:US $ 40.85M 7.4M